The VA has launched a trial to test Ozempic and Wegovy for alcohol use disorder in veterans.

People with alcohol use disorder taking oral semaglutide saw numerous improvements compared to placebo, a recent clinical ...

A clinical trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy ...

A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and ...

Pemvidutide 2.4 mg delivered a statistically significant and clinically meaningful reduction in heavy drinking days, the primary endpoint of the ...

A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and ...

Altimmune said on Tuesday its experimental drug ​helped patients with alcohol use disorder cut back on heavy ‌drinking in a ...

Altimmune’s Phase 2 trial showed Pemvidutide reduced heavy drinking by 4.20 days per week compared with the placebo’s 2.75 ...

A phase 2, randomized, double-blind trial (N=50) used oral semaglutide 3 mg/day then 7 mg/day, combining cue-reactivity testing with Timeline Follow-Back naturalistic drinking assessment and objective ...

Illustration courtesy of Vivian Chang This 3-part series looks at the current evidence for the treatment of SUDs. Part 2 reviews the use of GLP-1 receptor agonists and alcohol use disorder. Alcohol ...

For U.S. adult cancer survivors with a new alcohol use disorder (AUD) diagnosis, the one-year cumulative incidence of AUD treatment initiation was 14.3%, according to a research letter published ...